Clinical Research Directory
Browse clinical research sites, groups, and studies.
Suprachoroidal Triamcinolone Acetonide Monotherapy in Treatment-naive Center Involving Diabetic Macular Edema
Sponsor: Khyber Girls Medical College
Summary
The goal of this clinical trial is to evaluate whether a single injection of suprachoroidal triamcinolone acetonide (SCTA) improves visual outcomes in patients with treatment-naive diabetic macular edema involving the center of the macula. The study will also evaluate the safety of SCTA by monitoring for possible side effects, including an increase in intraocular pressure and cataract progression. Patients will be evaluated at the start of the study (baseline) and will receive one injection of SCTA. They will then be followed at 1, 3, and 6 months. At each follow-up visit, visual acuity, central macular thickness, intraocular pressure, and cataract status will be assessed to evaluate the effectiveness and safety of the treatment.
Official title: Outcomes of Suprachoroidal Triamcinolone Acetonide Monotherapy in Treatment-Naïve Center-Involving Diabetic Macular Edema
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2026-09-21
Completion Date
2027-06
Last Updated
2026-10-13
Healthy Volunteers
No
Conditions
Interventions
Suprachoroidal triamcinolone acetonide injection
4mg/0.1 ml, given once at baseline